G

Gubra A/S
CSE:GUBRA

Watchlist Manager
Gubra A/S
CSE:GUBRA
Watchlist
Price: 644 DKK 6.27% Market Closed
Market Cap: 10.5B DKK
Have any thoughts about
Gubra A/S?
Write Note

Gubra A/S
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gubra A/S
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
G
Gubra A/S
CSE:GUBRA
Research & Development
-kr43.1m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chemometec A/S
CSE:CHEMM
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Gubra A/S
Glance View

Market Cap
10.5B DKK
Industry
Life Sciences Tools & Services

Gubra ApS operates as biotechnology company. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.

GUBRA Intrinsic Value
61.22 DKK
Overvaluation 90%
Intrinsic Value
Price
G

See Also

What is Gubra A/S's Research & Development?
Research & Development
-43.1m DKK

Based on the financial report for Dec 31, 2023, Gubra A/S's Research & Development amounts to -43.1m DKK.

What is Gubra A/S's Research & Development growth rate?
Research & Development CAGR 3Y
-25%

Over the last year, the Research & Development growth was -16%. The average annual Research & Development growth rates for Gubra A/S have been -25% over the past three years .

Back to Top